
The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
09.06.2025
Gpi meets the investors: the June dates
June 11th 2025, European Midcap Event, in Paris and June 13th 2025, Frankfurt MidCap Event 2025 in Frankfurt
Investor
09.06.2025
Corofar Distribuzione chooses Riedl Phasys
€2.1 million contract signed for two automated systems dedicated to pharmaceutical logistics
Blog
03.06.2025
Digital Health transformation in Italy: data, tools and the role of GPI
Investments grows. Widespread adoption of telemedicine, EHR, and GenAI.